Pages that link to "Q53375835"
Jump to navigation
Jump to search
The following pages link to Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan. (Q53375835):
Displaying 31 items.
- Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review (Q22248003) (← links)
- High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment (Q30487873) (← links)
- Neurobiological early diagnosis of Alzheimer's disease (Q31117740) (← links)
- Novel MRI techniques in the assessment of dementia (Q31143141) (← links)
- Frequency of the apolipoprotein E ε4 allele in a memory clinic cohort in Beijing: a naturalistic descriptive study (Q33734175) (← links)
- Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P (Q33862145) (← links)
- The presymptomatic stage of neurodegenerative disorders (Q33971542) (← links)
- Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort (Q33996059) (← links)
- Functional and structural MR imaging in neuropsychiatric disorders, Part 1: imaging techniques and their application in mild cognitive impairment and Alzheimer disease (Q34102457) (← links)
- Apolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adults (Q35147749) (← links)
- Biological markers for early detection and pharmacological treatment of Alzheimer's disease (Q35237100) (← links)
- Structural neuroimaging of concomitant depressive symptoms in amnestic mild cognitive impairment: a pilot study. (Q36467283) (← links)
- Progression and predictors of mild cognitive impairment in Chinese elderly: A prospective follow-up in the Shanghai Aging Study (Q37107911) (← links)
- Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry (Q37185672) (← links)
- Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau (Q37226336) (← links)
- Alzheimer's disease and other dementing conditions (Q37305458) (← links)
- Familial risk for Alzheimer's disease alters fMRI activation patterns. (Q37348964) (← links)
- Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort (Q37394321) (← links)
- Connectivity features for identifying cognitive impairment in presymptomatic carotid stenosis (Q37484456) (← links)
- Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis (Q37706441) (← links)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Q37769104) (← links)
- Prospective memory impairment in mild cognitive impairment: an analytical review (Q37902968) (← links)
- Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease (Q38196409) (← links)
- Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease (Q38394521) (← links)
- Predictive Utility of Marketed Volumetric Software Tools in Subjects at Risk for Alzheimer Disease: Do Regions Outside the Hippocampus Matter? (Q38774326) (← links)
- Intervention versus Aggressive Medical Therapy for Cognition in Severe Asymptomatic Carotid Stenosis. (Q48056854) (← links)
- Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study (Q48382487) (← links)
- Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease (Q48422478) (← links)
- Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies (Q48691809) (← links)
- Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy. (Q55647343) (← links)
- Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases (Q64814709) (← links)